BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/29/2026 7:26:47 AM | Browse: 0 | Download: 0
 |
Received |
|
2025-12-28 08:55 |
|
Peer-Review Started |
|
2025-12-28 08:55 |
|
First Decision by Editorial Office Director |
|
2026-01-30 09:07 |
|
Return for Revision |
|
2026-01-30 09:07 |
|
Revised |
|
2026-02-06 12:58 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-03-09 02:46 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-03-09 08:45 |
|
Articles in Press |
|
2026-03-09 08:45 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-05-12 03:40 |
|
Publish the Manuscript Online |
|
2026-05-29 07:26 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Editorial |
| Article Title |
Beyond the score: Diet and exercise as modifiers of inflammation-based prognosis in lenvatinib-treated hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Héctor Vázquez-Lorente, Jorge Olivares-Arancibia and Julio Plaza-Diaz |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Julio Plaza-Diaz, Senior Postdoctoral Fellow, Senior Researcher, Biomedical Research Networking Center for Physiopathology of Obesity and Nutrition (CIBERObn), Alimentaciò, Nutrició Desenvolupament i Salut Mental, Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Carrer de Sant Llorenç 21, Reus 43201, Spain. julioramon.plaza@urv.cat |
| Key Words |
Hepatocellular carcinoma; Lenvatinib; Inflammation-based prognostic indices; Nutritional status; Sarcopenia; Anti-inflammatory diet; Exercise/physical activity |
| Core Tip |
This article comments on Wu et al’s work, highlighting the prognostic nutritional index (PNI) as a powerful predictor of survival in patients with hepatocellular carcinoma treated with lenvatinib. Beyond its prognostic performance, the key message is that PNI reflects a dynamic and potentially modifiable state integrating nutrition, inflammation, and immune competence. Unlike static tumor characteristics, PNI may be improved through targeted lifestyle, nutritional, and supportive-care interventions. This perspective reframes inflammation-based scores from passive risk stratifiers to actionable clinical tools, supporting a more proactive and personalized approach to patient management, alongside systemic therapy. |
| Publish Date |
2026-05-29 07:26 |
| Citation |
Vázquez-Lorente H, Olivares-Arancibia J, Plaza-Diaz J. Beyond the score: Diet and exercise as modifiers of inflammation-based prognosis in lenvatinib-treated hepatocellular carcinoma. World J Gastroenterol 2026; 32(22): 118191 |
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i22/118191.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v32.i22.118191 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
